Founded by Bernie Schaeffer, we provide stock news, options insights, and premium trading services to options traders

 

BACKED BY 170+ YEARS OF MARKET EXPERTISE

Get Schaeffer’s market outlook every Monday, straight to your inbox.

 

 
 
 
 
 
 
 
 
X
Trader watching stock market price action
Day trading options has gained immense popularity among traders who seek high returns within short time frames. Combining the flexibility of options with the fast-paced nature of day trading offers ... Day trading options has gained immense popularity among traders who seek high returns within short time frames. Combining the flexibility of options with the fast-paced nature of day trading offers opportunities for significant profits—but also carries notable risks. By mastering key day tra ... Keep Reading
Schaeffer’s Midday Market Check Daily Newsletter
Wall Street is mixed this afternoon as investors react to tech earnings and more tariff talk out of Washington. The Dow Jones Industrial Average (DJI) is down over 200 points, the S&P 500 Index ( ... Wall Street is mixed this afternoon as investors react to tech earnings and more tariff talk out of Washington. The Dow Jones Industrial Average (DJI) is down over 200 points, the S&P 500 Index (SPX) is in red territory, and the Nasdaq Composite (IXIC) is higher. For the week, however, all thre ... Keep Reading
T-Mobile stock, TMUS stock , T Mobile stock news
Wireless network stock T-Mobile US Inc (NASDAQ:TMUS) is down 9.2% at $238.17 at last glance, brushing off better-than-expected first-quarter earnings and revenue after disappointing subscriber growth. ... Wireless network stock T-Mobile US Inc (NASDAQ:TMUS) is down 9.2% at $238.17 at last glance, brushing off better-than-expected first-quarter earnings and revenue after disappointing subscriber growth. The company added 495,000 monthly bill-paying customers, outperforming AT&T (T) and Verizon (VZ ... Keep Reading
Pharmacy stocks, Pharmaceutical stocks, Online Pharmacy stocks
Pharmaceutical stocks are making headlines today, after two U.S.-based sector heavyweights stepped into the earnings confessional this morning and last night. Options traders are reacting accordingly. ... Pharmaceutical stocks are making headlines today, after two U.S.-based sector heavyweights stepped into the earnings confessional this morning and last night. Options traders are reacting accordingly. AbbVie Inc (NYSE:ABBV) is up 1.1% to trade at $182.53, after the company reported adjusted first-qu ... Keep Reading